Gsk Plc · LSE:GSK

Gsk — GlaxoSmithKline Consumer Healthcare — Q4 FY2017 Earnings Presentation

7 slides from Gsk's earnings presentation, May 2017

Slide 1: GlaxoSmithKline Consumer Healthcare Limited Financial Results Q4 16-17
GlaxoSmithKline Consumer Healthcare Limited Financial Results Q4 16-17
Slide 2: Quarter Highlights
Quarter Highlights Net Sales increased by 1.1% Rs 1,149 Cr Vs Rs 1,136 Cr mainly on account of increase in Domestic Sales by 2% Sales growth for the first time in financial year 8% increase in PBT: Underlying 1% (Interest on Income tax refund Rs 18 Cr) • 8% increase in Business Auxiliary income • Sa
Slide 3: Financial Performance: Q4 FY17
Financial Performance*: Q4 FY17 Q4 FY 17 Q4 FY 16 Growth% Sales 1,149 1,136 1% EBITDA 216 214 1% PBT 269 249 8% 7% 4% 7% 6% 38% 45% 93% Domestic Exports North South East West Exports *Sales and profit growth v/s quarter ending Mar 2016 INR in crores
Slide 4: Market Share
Market Share Hlx 44.8% Horlicks Extensions 16.5% Boost 11.2% Source – AC Nielsen; Value Market Share MAT Mar 17
Slide 5: FY17 Results
FY17 Results
Slide 6: Financial Performance: FY17
Financial Performance*: FY17 FY17 FY16 Growth % Sales 4362 4209 -3.5% EBITDA 832 838 -0.6% PBT 1010 1056 -4% Rs. 70 per share Proposed Dividend (Dividend Payout to 45%) *Sales and profit growth v/s year ending Mar 2016 INR in crores
Slide 7: Thank You
THANK YOU